Profil
Barbara Wan worked as VP-Project Leadership Research & Development at Cyteir Therapeutics, Inc. from 2020 to 2022.
Prior to that, she worked as Vice President-Project & Portfolio Management at Casebia Therapeutics LLC.
Dr. Wan holds a doctorate degree from Brandeis University.
Anciens postes connus de Barbara Wan
| Sociétés | Poste | Fin |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2022 |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Barbara Wan
| Brandeis University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
